Key result
Invasive intravascular imaging modalities, including IVUS, OCT, and NIRS, offer superior sensitivity for early detection and detailed plaque characterization of cardiac allograft vasculopathy compared to traditional coronary angiography.
Why the study?
Coronary angiography has limited ability to detect early or diffuse cardiac allograft vasculopathy, prompting the need for more sensitive invasive diagnostic imaging tools to guide earlier intervention.
Do advanced invasive imaging modalities improve the detection of early cardiac allograft vasculopathy in heart transplant recipients?
Do advanced invasive imaging modalities improve the detection of early cardiac allograft vasculopathy in heart transplant recipients?
Answers are grounded in this paper and cite their sources.
Advanced invasive imaging modalities like IVUS, OCT, and NIRS offer greater sensitivity than standard coronary angiography for detecting early cardiac allograft vasculopathy in heart transplant recipients.
Heart transplantation is the standard of care treatment for end-stage heart failure. Therapeutic advances including enhanced immunosuppression and aggressive infectious prophylaxis have led to increased life-expectancy following transplantation; however, cardiac allograft vasculopathy (CAV) remains a leading cause of morbidity and mortality. Although coronary angiography is the current guideline-recommended diagnostic modality for invasive CAV screening, it is limited in its ability to detect early and/or diffuse disease. Efforts to improve outcomes for heart transplant recipients with CAV have focused on developing diagnostic tools with greater sensitivity to capture early CAV in order to better understand the pathobiology and implement treatment to slow disease progression sooner after transplant. The contemporary invasive imaging armamentarium for CAV surveillance includes coronary angiography, intravascular ultrasound, and newer technologies including optical coherence tomography and near-infrared spectroscopy. The present review outlines the use of and data in support of these imaging platforms in the CAV arena and highlights the potential advantages and limitations of each of these modalities.
No takes yet. Share an insight, caveat, or question.
Shahandeh et al. (2022) conducted a review in Cardiac Allograft Vasculopathy. Invasive Coronary Imaging (IVUS, OCT, NIRS) vs. Coronary angiography was evaluated. Invasive intravascular imaging modalities, including IVUS, OCT, and NIRS, offer superior sensitivity for early detection and detailed plaque characterization of cardiac allograft vasculopathy compared to traditional coronary angiography.
Synapse has enriched 10 related papers. Consider them for comparative context: